| K-number | K232669 |
| Device name | TBI |
| Applicant | Abbott Laboratories |
| Product code | QAT |
| Device class | Class II |
| Decision date | Sep 29, 2023 |
| Decision | Substantially Equivalent |
| Regulation | 866.5830 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov